United State of America
2015 Oct 01
United State of America
2015 Oct 01
United State of America
2015 Oct 01
United State of America
2015 Oct 01
United State of America
2015 Oct 01
United State of America
2015 Oct 01
United State of America
2015 Oct 01
Australia
The Catholic Church in Australia has changed dramatically in the last fifty years. The Catholics in Australia 2022 survey project aimed to map the impact of some of these changes on Australian Catholics' ways of believing, behaving, and belonging, to see what this might reveal about the future of the Church in Australia. The project was informed by the work of Ben Clements and Stephen Bullivant, who mapped a more general UK Catholic cohort using a similar survey (Clements & Bullivant, 2022). The Catholics in Britain 2019 survey was adapted for the Australian study and collected mostly quantitative data with a final open-text question for optional comments. The project was approved by the University of Notre Dame Human Research Ethics Committee (HREC 2022-119S).
Australia
Objectives This study evaluated the uptake of Western Australian (WA) pharmacist vaccination services, the profiles of consumers being vaccinated and the facilitators and challenges experienced by pharmacy staff in the preparation, implementation and delivery of services. Design Mixed-methods methodology with both quantitative and qualitative data through surveys, pharmacy computer records and immuniser pharmacist interviews. Setting Community pharmacies in WA that provided pharmacist vaccination services between March and October 2015. Participants Immuniser pharmacists from 86 pharmacies completed baseline surveys and 78 completed exit surveys; computer records from 57 pharmacies; 25 immuniser pharmacists were interviewed. Main outcome measures Pharmacy and immuniser pharmacist profiles; pharmacist vaccination services provided and consumer profiles who accessed services. Results 15 621 influenza vaccinations were administered by immuniser pharmacists at 76 WA community pharmacies between March and October 2015. There were no major adverse events, and <1% of consumers experienced minor events which were appropriately managed. Between 12% and 17% of consumers were eligible to receive free influenza vaccinations under the National Immunisation Program but chose to have it at a pharmacy. A high percentage of vaccinations was delivered in rural and regional areas indicating that provision of pharmacist vaccination services facilitated access for rural and remote consumers. Immuniser pharmacists reported feeling confident in providing vaccination services and were of the opinion that services should be expanded to other vaccinations. Pharmacists also reported significant professional satisfaction in providing the service. All participating pharmacies intended to continue providing influenza vaccinations in 2016. Conclusions This initial evaluation of WA pharmacist vaccination services showed that vaccine delivery was safe. Convenience and accessibility were important aspects in usage of services. There is scope to expand pharmacist vaccination services to other vaccines and younger children; however, government funding to pharmacists needs to be considered.